Cimicifugin, a broad-spectrum inhibitor of Theileria annulata and Plasmodium falciparum CDK7
Article in Antimicrobial Agents and Chemotherapy (July 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Selective CDK7 inhibition suppresses cell cycle progression and MYC signaling while enhancing apoptosis in therapy-resistant estrogen receptor positive breast cancer
Article in Clinical Cancer Research (February 2024)
Therapeutic Path to Triple Knockout: Investigating the Pan-inhibitory Mechanisms of AKT, CDK9, and TNKS2 by a Novel 2-phenylquinazolinone Derivative in Cancer Therapy- An In-silico Investigation Therapy
Article in Current Pharmaceutical Biotechnology (January 2024)